392 related articles for article (PubMed ID: 10692930)
1. Human aqueous and vitreous humour levels of ciprofloxacin following oral and topical administration.
Cekiç O; Batman C; Yasar U; Başci NE; Bozkurt A; Kayaalp SO
Eye (Lond); 1999 Aug; 13 ( Pt 4)():555-8. PubMed ID: 10692930
[TBL] [Abstract][Full Text] [Related]
2. Comparison of aqueous humour and vitreous humour levels of two 0.3% ciprofloxacin eyedrops.
Cekiç O; Batman C; Yasar U; Basci NE; Bozkurt A; Kayaalp SO
Can J Ophthalmol; 1998 Dec; 33(7):373-6. PubMed ID: 9885752
[TBL] [Abstract][Full Text] [Related]
3. Aqueous humour levels of topically applied ciprofloxacin and ofloxacin in the same subjects.
Cekiç O; Batman C; Totan Y; Yasar U; Basci NE; Bozkurt A; Kayaalp SO; Zilelioglu O
Eye (Lond); 1999 Oct; 13 ( Pt 5)():656-9. PubMed ID: 10696321
[TBL] [Abstract][Full Text] [Related]
4. Penetration of ofloxacin in human aqueous and vitreous humors following oral and topical administration.
Cekic O; Batman C; Yasar U; Basci NE; Bozkurt A; Kayaalp SO
Retina; 1998; 18(6):521-5. PubMed ID: 9869460
[TBL] [Abstract][Full Text] [Related]
5. Penetration of topical and oral ciprofloxacin into the aqueous and vitreous humor in inflamed eyes.
Oztürk F; Kortunay S; Kurt E; Ilker SS; Basci NE; Bozkurt A
Retina; 1999; 19(3):218-22. PubMed ID: 10380027
[TBL] [Abstract][Full Text] [Related]
6. Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration.
Fiscella RG; Lai WW; Buerk B; Khan M; Rodvold KA; Pulido JS; Labib S; Shapiro MJ; Blair NP
Ophthalmology; 2004 Jun; 111(6):1191-5. PubMed ID: 15177970
[TBL] [Abstract][Full Text] [Related]
7. Vitreous and aqueous penetration of orally and topically administered moxifloxacin.
Fukuda M; Shibata N; Osada H; Yamashiro Y; Sasaki H
Ophthalmic Res; 2011; 46(3):113-7. PubMed ID: 21325873
[TBL] [Abstract][Full Text] [Related]
8. Penetration of ofloxacin and ciprofloxacin in aqueous humor after topical administration.
Cekiç O; Batman C; Totan Y; Yasar U; Basci NE; Bozkurt A; Kayaalp SO
Ophthalmic Surg Lasers; 1999 Jun; 30(6):465-8. PubMed ID: 10392734
[TBL] [Abstract][Full Text] [Related]
9. Penetration of topical 0.3% ciprofloxacin into human aqueous humor.
Kalayci D; Basci N; Akpek E; Hasiripi H; Bozkurt A
Ophthalmic Surg Lasers; 1996 Jan; 27(1):21-4. PubMed ID: 8630751
[TBL] [Abstract][Full Text] [Related]
10. Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy.
Lai WW; Chu KO; Chan KP; Choy KW; Wang CC; Tsang CW; Pang CP
Am J Ophthalmol; 2007 Aug; 144(2):315-8. PubMed ID: 17659971
[TBL] [Abstract][Full Text] [Related]
11. Penetration of topically applied ciprofloxacin and ofloxacin into the aqueous humor and vitreous.
Yalvac IS; Basci NE; Bozkurt A; Duman S
J Cataract Refract Surg; 2003 Mar; 29(3):487-91. PubMed ID: 12663011
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin and ofloxacin aqueous humor concentrations after topical administration in dogs undergoing cataract surgery.
Yu-Speight AW; Kern TJ; Erb HN
Vet Ophthalmol; 2005; 8(3):181-7. PubMed ID: 15910371
[TBL] [Abstract][Full Text] [Related]
13. Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model.
Yağci R; Oflu Y; Dinçel A; Kaya E; Yağci S; Bayar B; Duman S; Bozkurt A
Eye (Lond); 2007 Jul; 21(7):990-4. PubMed ID: 16732216
[TBL] [Abstract][Full Text] [Related]
14. Penetration of oral and topical ciprofloxacin into the aqueous humour.
Ghazi-Nouri SM; Lochhead J; Mearza AA; Qureshi MA; Thompson GM; Cowdrey G; Firth M; Moss R; Karim AK; Firth G
Clin Exp Ophthalmol; 2003 Feb; 31(1):40-3. PubMed ID: 12580892
[TBL] [Abstract][Full Text] [Related]
15. An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification.
Bucci FA
Am J Ophthalmol; 2004 Feb; 137(2):308-12. PubMed ID: 14962422
[TBL] [Abstract][Full Text] [Related]
16. Aqueous and vitreous penetration of ciprofloxacin following different modes of systemic administration.
Madu AA; Mayers M; Perkins R; Liu W; Drusano GL; Aswani R; Madu CN; Miller MH
Exp Eye Res; 1996 Aug; 63(2):129-36. PubMed ID: 8983970
[TBL] [Abstract][Full Text] [Related]
17. Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration.
Hariprasad SM; Mieler WE; Shah GK; Blinder KJ; Apte RS; Holekamp NM; Thomas MA; Chi J; Prince RA
Trans Am Ophthalmol Soc; 2004; 102():149-55; discussion 155-7. PubMed ID: 15747753
[TBL] [Abstract][Full Text] [Related]
18. Ofloxacin penetration into the eye after intravenous and topical administration.
Fiscella RG; Shapiro MJ; Solomon MJ; Kurtz RM; Mui S; Labib S
Retina; 1997; 17(6):535-9. PubMed ID: 9428017
[TBL] [Abstract][Full Text] [Related]
19. Vitreous penetration of orally administered gatifloxacin in humans.
Hariprasad SM; Mieler WF; Holz ER
Trans Am Ophthalmol Soc; 2002; 100():153-9. PubMed ID: 12545689
[TBL] [Abstract][Full Text] [Related]
20. Aqueous and vitreous penetration of levofloxacin after oral administration.
Fiscella RG; Nguyen TK; Cwik MJ; Phillpotts BA; Friedlander SM; Alter DC; Shapiro MJ; Blair NP; Gieser JP
Ophthalmology; 1999 Dec; 106(12):2286-90. PubMed ID: 10599658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
